Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Seena Hassouna - ENAVATE's Zenas Bio Pharma add Is a Footnote - The Obexelimab Pipeline Is What to Watch
ENAVATE's Zenas Bio Pharma add Is a Footnote - The Obexelimab Pipeline Is What to Watch
The Motley Fool

On February 17, 2026, ENAVATE Sciences GP, LLC disclosed a buy of 157,800 shares of Zenas BioPharma (ZBIO 4.58%), an estimated $5.19 million trade based on quarterly average pricing. ENAVATE Sciences added 157,800 shares of Zenas BioPharma, an…

thehindu.com - N. Ravi Kumar - Sun Pharma, Dr. Reddy's, Zydus, Glenmark roll out generic Semaglutide
Sun Pharma, Dr. Reddy's, Zydus, Glenmark roll out generic Semaglutide
The Hindu

Sun Pharmaceutical, Dr. Reddy's Laboratories, Zydus Life Sciences, and Glenmark Pharmaceuticals rolled out generic versions of Semaglutide on March 21, following the expiration of the patent on the active ingredient in Danish major Novo Nordisk's…

thehindubusinessline.com - Torrent Pharma brings India's first oral semaglutide, launches injectable at ₹3,999/month
Torrent Pharma brings India's first oral semaglutide, launches injectable at ₹3,999/month
BusinessLine

Torrent Pharmaceuticals on Saturday said it has become the first company in India to introduce a generic oral version of semaglutide, while also launching an injectable format, expanding treatment options for diabetes and obesity patients. The…

thehindubusinessline.com - Day 1, semaglutide patent expiry: Sun Pharma, Zydus Lifesciences launch generic versions
Day 1, semaglutide patent expiry: Sun Pharma, Zydus Lifesciences launch generic versions
BusinessLine

Sun Pharmaceutical Industries has announced the launch of its semaglutide injection under the brands Noveltreat and Sematrinity in India – for chronic weight management in adults and Tye II diabetes, respectively. “Priced…

marketbeat.com - NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of 'Moderate Buy' by Brokerages
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of 'Moderate Buy' by Brokerages
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has been given a consensus rating of 'Moderate Buy' by the twelve research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated…

newsbytesapp.com - Dwaipayan Roy - Torrent Pharma launches India's 1st generic oral substitute to Ozempic
Torrent Pharma launches India's 1st generic oral substitute to Ozempic
NewsBytes

What's the story Torrent Pharmaceuticals has launched India's first generic oral version of semaglutide, a drug used to treat diabetes and obesity. The company has introduced the medication under the brand names Sembolic and Semalix. The injectable…

mirror.co.uk - Mia O'Hare - Urgent product recalls for sun cream, beauty products and medication this week
Urgent product recalls for sun cream, beauty products and medication this week
The Mirror

Several popular products have been recalled from customers this week, and many were told to stop using them 'immediately'. The Office for Product Safety and Standards (OPSS) issued product recall notices, warning anyone with the items about the…

fool.com - Micah Zimmerman - Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.
The Motley Fool

Turning $10,000 into $1 million over a decade requires a 100x return. That only happens when you invest in companies at the start of a structural shift that positions them to take advantage of a massive market that isn't currently being served…

nationalpost.com - Bloomberg News - India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
National Post

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S's blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest overweight population. Natco Pharma Ltd. plans to make an…

indianexpress.com - Geeta Nair - Weight-loss drug prices down 70-90%, to cost as low as Rs 1,290 per month as generics hit the shelves
Weight-loss drug prices down 70-90%, to cost as low as Rs 1,290 per month as generics hit the shelves
The Indian Express

In a shot in the arm for India's high-growth weight-loss drugs market, generic versions of Danish drugmaker Novo Nordisk's blockbuster drug semaglutide will hit the shelves on Saturday, with price discounts as deep as 70-90%. The patent on the…

thehindubusinessline.com - Generic versions of Novo Nordisk's semaglutide begin to flow, priced 50-80% lower than the innovator
Generic versions of Novo Nordisk's semaglutide begin to flow, priced 50-80% lower than the innovator
BusinessLine

The trickle has become a flow of generic semaglutide – the active ingredient in Novo Nordisk's Wegovy (for obesity) and Ozempic (for Type II diabetes). At least seven major drugmakers announced the launch of their generic versions of…

sciencedaily.com - Harvard engineers build chip that can twist and control light in real time
Harvard engineers build chip that can twist and control light in real time
ScienceDaily

The project was led by graduate student Fan Du in the lab of Eric Mazur, the Balkanski Professor of Physics and Applied Physics. The team designed a reconfigurable twisted bilayer photonic crystal that can be adjusted in real time using an…

indianexpress.com - IE Online - UP govt preparing for 5th groundbreaking event to launch projects worth Rs 7.5 lakh crore
UP govt preparing for 5th groundbreaking event to launch projects worth Rs 7.5 lakh crore
The Indian Express

2 min read Lucknow Make us preferred source on Google The state government is preparing for the fifth groundbreaking ceremony to launch new projects worth Rs 7.5 lakh crore, an official said on Friday, adding that through four ceremonies, projects…

express.co.uk - Mia O'Hare - Urgent product recall alerts for sun cream, power banks and medication this week
Urgent product recall alerts for sun cream, power banks and medication this week
Express.co.uk

A number of popular items have been recalled this week Several popular products have been withdrawn from consumers this week, with many being instructed to cease using them 'immediately'. The Office for Product Safety and Standards (OPSS) has…

marketbeat.com - Best Growth Stocks To Watch Now - March 21st
Best Growth Stocks To Watch Now - March 21st
MarketBeat

3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Tyra Biosciences, Acadia Realty Trust, and Hercules Capital are the seven Growth stocks to watch today…

Receive a Daily briefing on Pharma Industry News

Get Started